Classification | Clinical trial | Application Catatgory | Monitoring period |
1 Innovative drugs that are not marketed both domestically and abroad |
Phase I, Il and Ill Clinical trial |
New drug |
5 years |
2 Modified new drugs that are not marketed both domestically and abroad |
Phase I, Il and Ill Clinical trial |
New drug |
2.1: 3 years 2.2: 4 years 2.3: 4 years 2.4: 3 years |
3 The drugs that are imitated by domestic applications to original drugs that have been marteted abroad but not domestically |
Pharmacokinetics (PK) and Phase Ill Clinical trial |
Domestic generic drug |
0 year |
4 The drugs that are imitated by domestic applicants to original drugs that have been marketed domestically |
Bioequivalence (BE) study |
Domestic generic drug |
0 year |
5.1 Original drugs (including API and its preparation) that have been marketed abroad are applied to be marketed domestically |
Pharmacokinetics (PK) and Phase Ill Clinical trial |
Imported innovative drug |
0 year |
5.2 Non-original drugs (including API and its preparation) that have been marketed abroad are applied to be marketed domestically |
Bioequivalence (BE) study |
Imported generic drug |
0 year |